Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale

Tools

MONTEJO, Angel L, DEAKIN, JFW, GAILLARD, Raphael, HARMER, Catherine, MEYNIEL, Florent, JABOURIAN, Artin, GABRIEL, Cecilia, GRUGET, Celine, KLINGE, Corinna, MACFAYDEN, Christine, MILLIGAN, Holly, MULLINGS, Emma and GOODWIN, Guy (2015). Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale. Journal of Psychopharmacology, 29 (10), 1119-1128. [Article]

[+][-]

Documents

23496:543274

[+][-]

23496:543274

[thumbnail of Mullings_Better_Sexual_Acceptability.pdf]

Preview

PDF
Mullings_Better_Sexual_Acceptability.pdf

Download (325kB) | Preview

Abstract

The present double-blind, placebo-controlled study evaluates the effects of agomelatine and the selective serotonin reuptake inhibitor escitalopram on sexual dysfunction in healthy men and women.

More Information

Official URL:

https://journals.sagepub.com/doi/10.1177/026988111...

Uncontrolled Keywords:

11 Medical And Health Sciences; 17 Psychology And Cognitive Sciences; Psychiatry

Page Range:

1119-1128

Identifiers

Identification Number:

10.1177/0269881115599385

ORCID:

https://orcid.org/0000-0001-5718-5112